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The human gut symbiont Ruminococcus gnavus scavenges
host-derived N-acetylneuraminic acid (Neu5Ac) from mucins
by converting it to 2,7-anhydro-Neu5Ac.We previously showed
that 2,7-anhydro-Neu5Ac is transported into R. gnavus ATCC
29149 before being converted back to Neu5Ac for further meta-
bolic processing. However, the molecular mechanism leading to
the conversion of 2,7-anhydro-Neu5Ac to Neu5Ac remained
elusive. Using 1D and 2D NMR, we elucidated the multistep en-
zymatic mechanism of the oxidoreductase (RgNanOx) that leads
to the reversible conversion of 2,7-anhydro-Neu5Ac to Neu5Ac
through formation of a 4-keto-2-deoxy-2,3-dehydro-N-acetyl-
neuraminic acid intermediate and NAD1 regeneration. The
crystal structure of RgNanOx in complex with the NAD1 cofac-
tor showed a protein dimer with a Rossman fold. Guided by the
RgNanOx structure, we identified catalytic residues by site-
directed mutagenesis. Bioinformatics analyses revealed the
presence of RgNanOx homologues across Gram-negative and
Gram-positive bacterial species and co-occurrence with sialic
acid transporters. We showed by electrospray ionization spray
MS that the Escherichia coli homologue YjhC displayed activity
against 2,7-anhydro-Neu5Ac and that E. coli could catabolize
2,7-anhydro-Neu5Ac. Differential scanning fluorimetry analyses
confirmed the binding of YjhC to the substrates 2,7-anhydro-
Neu5Ac and Neu5Ac, as well as to co-factors NAD and NADH.
Finally, using E. coli mutants and complementation growth
assays, we demonstrated that 2,7-anhydro-Neu5Ac catabolism in
E. coli depended on YjhC and on the predicted sialic acid trans-
porter YjhB. These results revealed the molecular mechanisms of
2,7-anhydro-Neu5Ac catabolism across bacterial species and a
novel sialic acid transport and catabolism pathway in E. coli.
The sialic acids comprise a family of 9-carbon sugar acids
found predominantly on cell-surface glycans of humans and
other animals (1). Sialic acids are subject to a remarkable num-
ber of modifications, generating more than 50 structurally dis-
tinct molecules. Their terminal location makes them a prefer-
ential target for interaction with viruses and microorganisms at
mucosa surfaces across the body (1). N-Acetylneuraminic acid
(Neu5Ac), the most common form of sialic acid in humans, is a
major epitope of mucin glycans that can serve as a metabolic
substrate to the gut bacteria that have adapted to the mucosal
environment (2). Most of our knowledge on sialic acid metabo-
lism in bacteria comes from the study of Neu5Ac using the
model organism Escherichia coli (3). We previously reported
that sialic acid metabolism is vital to the ability of Ruminococ-
cus gnavus strains to utilize mucin as a nutrient source through
the production of 2,7-anhydro-Neu5Ac derivative (4, 5).
R. gnavus is a human gut symbiont that plays a major role in
human health and disease. R. gnavus is widely distributed among
individuals being represented in the most common 57 species
present in90% of individuals (6). Colonization by R. gnavus has
been found in infants during the first days of life. R. gnavus is in
the top 15 species showing abundance in both adult and infant
gut-enriched genes, supporting R. gnavus adaptation to the in-
testinal habitat throughout life (6, 7). Further, R. gnavus has been
associated with an increasing number of intestinal or extraintes-
tinal diseases, including inflammatory bowel disease (8–16).
The mucin-foraging strategy of R. gnavus is strain-specific
(5) and associated with the expression of an intramolecular
trans-sialidase (IT-sialidase) that targets and cleaves off termi-
nal a2-3–linked Neu5Ac from glycoproteins, releasing 2,7-
anhydro-Neu5Ac instead of Neu5Ac (4, 17, 18). We unraveled
themolecular pathway leading to the transport andmetabolism
of 2,7-anhydro-Neu5Ac in R. gnavus ATCC 29149 (19). The
2,7-anhydro-Neu5Ac compound binds specifically to the sub-
strate-binding protein (RgSBP), which forms part of an ABC
sialic acid transporter in R. gnavus. Once inside the cell, 2,7-
anhydro-Neu5Ac is converted into Neu5Ac via a novel en-
zymatic reaction catalyzed by an oxidoreductase, RgNanOx.
Following this conversion, Neu5Ac is then catabolized into
N-acetylmannosamine (ManNAc) and pyruvate via the action
of a Neu5Ac-specific aldolase (19). We confirmed the impor-
tance of thismetabolic pathway in vivo by generating a R. gnavus
nan cluster deletionmutant that lost the ability to grow on sialy-
lated substrates. We showed that in gnotobiotic mice colonized
with R. gnavus WT and mutant strains, the fitness of the nan
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mutant was significantly impaired as compared with the WT
strain with a reduced ability to colonize themucus layer (19).
The novel oxidoreductase identified in our work showed to
catalyze the conversion 2,7-anhydro-Neu5Ac to Neu5Ac in the
presence of NAD1 in a reversible manner (19). Recently, the
crystal structure of the RgNanOx homologue in E. coli, YjhC,
was solved in complex with NAD1 (20). However, the mecha-
nism of action of these newly identified enzymatic activities
remained undefined. Here, using a combination of in silico, mo-
lecular, biochemical, and structural approaches, we elucidated
the molecular mechanism of RgNanOx and showed that homol-
ogous enzymes are present across both Gram-positive and
Gram-negative bacteria and are associated with different classes
of predicted transporters. We validated these data in vitro and
further unraveled the 2,7-anhydro-Neu5Ac catabolism in E. coli.
Results
Characterization of R. gnavus oxidoreductase (RgNanOx)
reaction revealed a novel mechanism involving a 4-keto-2-
deoxy-2,3-dehydro-N-acetylneuraminic acid (4-keto-DANA)
intermediate
RgNanOx (RUMGNA_02695) from R. gnavus ATCC 29149
catalyzes the equilibration of 2,7-anhydro-Neu5Ac and Neu5Ac
(19). To gain insights into the mechanism of action of the
enzyme, the conversion of 2,7-anhydro-Neu5Ac to Neu5Ac was
monitored by 1HNMR for 24 h. Comparison of samples differing
only in the solvent (light water (H2O) versus deuterated water
(D2O) at the same reaction time points showed the loss of specific
1H signals from protons attached at C3 andC5 inD2O, indicating
solvent exchange. The loss of these signals led to simplification in
the splitting of the neighboring proton signals (Fig. S1).
Analysis of the reaction curve, obtained by monitoring the
signals from the methyl protons of the acetamide group at C5,
revealed the presence of a new (third) molecule (XY). This mol-
ecule is formed with a very fast kinetics, reaching its highest
concentration at very early time (Fig. 1A). The reactionmixture
was analyzed by 2DNMR during the interval at which the inter-
mediate was at its highest concentration, using a 600-MHz
spectrometer equipped with a cryoprobe. The comparison of
the 2D 1H,13C HSQC spectra of the substrate (2,7-anhydro-
Neu5Ac), the product (Neu5Ac), and the reaction mixture at
30 min allowed the identification of an additional set of cross-
peaks that did not belong to the substrate or to the product and
were therefore assigned to the intermediate (Fig. 1, B and C).
Specifically, the presence of a heteronuclear cross-peak at 2.73
ppm/43.1 ppm (1H/13C) (signal 2 in Fig. 1B), characteristic of a
Figure 1. NMR characterization of the RgNanOx-catalyzed enzymatic reaction. A, 1H 1D NMR analysis of the conversion of 2,7-anhydro-Neu5Ac to
Neu5Ac via the XY intermediate; evolution of the concentrations of substrate, product, and intermediate of the reaction, [X] (mM), by integration of the acetyl
methyl groups for Neu5Ac (blue), 2,7-anhydro-Neu5Ac (orange), or XY intermediate (gray). B and C, superposition of the 1H,13C HSQC reference spectra of
Neu5Ac (blue) and 2,7-anhydro-Neu5Ac (orange) and 1H,13C HSQC reaction mixture at 30 min (where the XY peak is observed to peak, gray). Proton-carbon
peaks corresponding to neither Neu5Ac nor 2,7-anhydro-Neu5Ac are numbered from 1 to 6 and circled in green.
Structural basis of 2,7-anhydro-Neu5Ac catabolism
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proton in a to a keto group, strongly suggested the intermedi-
ate to be a keto-sugar. Homonuclear 2D 1H,1H COSY and
1H,1H TOCSY experiments showed connectivity of this proton
to one and two other protons, respectively (Fig. S2). Signal 2, at
2.73 ppm, corresponds then to a proton neighboring a carbonyl
on one side and at least two other protons on the other side
with chemical shifts in the 3–4 ppm region. Analysis of the 3–4
ppm spectral region, where standard sugar-ring C-H signals
typically show, suggests that the intermediate chemical shifts
are closer to Neu5Ac than to 2,7-anhydro-Neu5Ac (Fig. S3).
Based on this information, we proposed that in this species, the
glycerol moiety is in the open form, indicating that the 2,7-
anhydro bond is broken in the intermediate. The formation of
such an oxidized intermediate (i.e. the keto-sugar), as detected
by NMR, is compatible with the regeneration of NAD1
observed previously (19). As the final result of the reaction is a
reductive opening of the ring through the O7–C2 bond, a pre-
liminary oxidationmust occur earlier in themechanism.
Based on this analysis, we propose a multistep mechanism
for the reversible conversion of 2,7-anhydro-Neu5Ac to
Neu5Ac by RgNanOx (Fig. 2). In the first step, 2,7-anhydro-
Neu5Ac is oxidized at the C4 keto by NAD1 cofactor. The pro-
ton at C3 is now a to the keto group and thus more acidic and
can be abstracted in an anti-periplanar elimination reaction in
which the 2,7-anhydro bond is also broken. The resulting com-
pound, 4-keto-DANA, is consistent with 2D NMR, and the
conjugation would be expected to stabilize the intermediate
(full NMR assignment of 4-keto-DANA is given in Table S1). 4-
Keto-DANA exists as an equilibrium between two ring-flipped
forms; however, the form with the equatorial glycerol and N-
acetyl substituents would be expected to predominate. In this
ring-flipped form, a Michael addition of water to C2 hydrates
Figure 2. Proposed mechanism for the reversible conversion of Neu5Ac to 2,7-anhydro-Neu5Ac by RgNanOx. The reaction is shown in the favorable
direction converting 2,7-anhydro-Neu5Ac (1) to Neu5Ac (6). The order of events taking compound 2 to compound 4, including the opening of the 2,7 second-
ary ring and the primary ring flip, has yet to be determined. The red arrows indicate the keto enol tautomerization of compound 5 that allows for the C5 hydro-
gen exchange.
Structural basis of 2,7-anhydro-Neu5Ac catabolism
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the C2=C3 double bond with a proton from the solvent added
to C3. The addition reaction would be expected to follow the
expected anti-periplanar geometry. This is consistent with the
NMR observation that the axial, not equatorial proton, under-
goes exchange (Fig. S1). The product of the addition (2) is a 4-
keto-Neu5Ac, in which the proton at C5 is now a to the keto
and acidic. This acidic proton will exchange with solvent by the
well-known keto enol tautomerization reaction, consistent
with the NMR data (Fig. S1). The 4-keto-Neu5Ac (2) is finally
reduced by NADH to yield the final Neu5Ac product and
NAD1. The regeneration of NAD1 also explains why no net
change in the ratio of NAD1 and NADH was observed in the
enzymatic reaction (19).
The crystal structure of RgNanOx in complex with NAD1
confirms structural homology with short-chain
dehydrogenase/reductases
The crystal structure of the recombinant RgNanOx in com-
plex with the NAD1 cofactor was solved at 2.58 Å and subse-
quently at 1.74Å usingmolecular replacement with an oxidore-
ductase from Agrobacterium radiobacter as a model (Protein
Data Bank (PDB) entry 5UI9). The protein shows a Rossman
fold typical of NAD-binding protein of the Gfo/Idh/MocA class
(21) characterized by a central b-sheet with helices on either
side. RgNanOx forms a dimer in the asymmetric unit, and the
NAD1 cofactor can be seen bound to the protein (Fig. 3A). A
structural similarity search (22) identifies multiple oxidoreduc-
tase enzymes, all of which share the same Rossman fold and
location of the nucleotide-binding site. Oxidoreductase pro-
teins typically have a catalytic triad of K (found in the EKP
motif), D, and H (often found as a DXXXH motif; in some
enzymes Y replaces the H) and a fourth residue, which is posi-
tively charged (21). RgNanOx has Lys-93 and His-178 which
correspond to the Lys and His of the catalytic triad, and Lys-
163 occupies the “fourth” position (23). However, RgNanOx
has His-175, which occupies the position typical for the Asp in
the catalytic triad (23). The closest structural match (0.8 Å over
341 residues) is the recently solved crystal structure of YjhC
oxidoreductase from E. coli (Fig. 3B) (20), which also has a
HXXH motif. In the RgNanOx structure, there is additional
density adjacent to the nicotinamide ring that, given the high
resolution of the second structure, we were able to unambigu-
ously identify as citric acid from the crystallization buffer.
Using the high-resolution structure, we used a simple model-
ing approach to place a molecule of DANA a transition state
analog inhibitor of sialidases, in RgNanOx active site by over-
lapping the carboxylate acid of the DANA with each of the
three carboxylate groups of citric acid. Next we manually posi-
tioned the sugar such that the H3 of the atom ring pointed to-
ward the C49 of the nicotinamide, as would be required for
hydride transfer. These models were then minimized, and we
investigated whether the H4 atom of DANA was still able to
transfer to nicotinamide. Only one position (Fig. 3C) where the
DANA carboxylate was placed on the 2-carboxylic acid of citric
remained positioned for hydride transfer. The goal of modeling
was not to generate a precise model of the substrate protein
interactions but rather, along with sequence comparisons, gen-
erate hypotheses for site-directed active-site mutagenesis. The
model indicated that His-178, predicted to be a catalytic resi-
due, is positioned to remove the proton fromO4 during the ox-
idation step. His-176 is plausibly positioned to undertake pro-
ton transfer with the O7 of the substrate glycerol that the
Figure 3. Crystal structure of RgNanOx. A, dimeric structure of RgNanOx shown in cartoon formatwith the NAD cofactor bound (spheres). B, structure of pu-
tative active site of RgNanOx; the protein backbone is shown in cartoonwith residues NAD and citric acid shown in sticks. C, crystal structure of RgNanOx with
key residuesmarked and DANAmodeled into the active site. The red linemarks the trajectory of hydride transfer.
Structural basis of 2,7-anhydro-Neu5Ac catabolism
J. Biol. Chem. (2020) 295(40) 13724–13736 13727
 by guest on O
ctober 3, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
mechanism requires. His-175 interacts with the negatively
charged carboxylic acid in the model but could play a role in
proton transfer at the substrate C3 atom. Lys-93 binds to
NAD1, is part of the catalytic constellation, and is also within a
plausible distance for proton transfer to C3. Lys-163 binds to
the NAD1 co-factor and interacts with the substrate carboxy-
late. The following mutants of RgNanOx were constructed:
K93A, K163A, H175A, H176A, and H178A. The purified
mutants lost enzymatic activity, as demonstrated by electro-
spray ionization spray MS (ESI-MS) (Fig. 4A), supporting the
hypothesis that they are catalytically important. K93A lost the
ability to bind NAD1; as did H176A, to some extent. The other
mutants appeared able to retain substrate binding (Fig. 4B).
Catabolism of 2,7-anhydro-Neu5Ac by E. coli requires a
RgNanOx homologue (YjhC) and a novel transporter
Sequence similarity network analysis of the R. gnavus Nan
cluster (responsible for 2,7-anhydro-Neu5Ac metabolism)
identified the presence of RgNanOx homologues in a number
of organisms (19). One such example was themodel Gram-neg-
ative human commensal E. coli K-12, the organism in which
the genes for Neu5Ac catabolism were first discovered (24, 25).
In E. coli, the homologue of RgNanOx is part of a two-gene op-
eron, yjhBC, which is one of only three operons in E. coli regu-
lated by the transcription factor NanR as reported previously
(25) (Fig. 5A). Here, we demonstrated that E. coli could grow on
2,7-anhydro-Neu5Ac as a sole carbon source (Fig. 5B), reaching
growth yields similar to that obtained when E. coli was grown
on Neu5Ac. Deletion of yjhC resulted in loss of growth on 2,7-
anhydro-Neu5Ac but not on Neu5Ac (Fig. 5C), which could be
complemented in trans with yjhC (Fig. 5D), suggesting that the
gene encodes an equivalent protein to RgNanOx. To test this
hypothesis, the YjhC protein was recombinantly expressed and
purified, and its activity against 2,7-anhydro-Neu5Ac and
Neu5Ac was analyzed by ESI-MS. The purified enzyme was
shown to be active against both substrates, reaching an equilib-
rium of 2:1 Neu5Ac/2,7-anhydro-Neu5Ac, in line with that of
RgNanOx (19) (Fig. 6A). Differential scanning fluorimetry
(DSF) analyses confirmed the binding of YjhC to the substrates
2,7-anhydro-Neu5Ac and Neu5Ac as well as to co-factor NAD
or NADH (Fig. 6B), as shown previously for RgNanOx (19). The
knowledge of the biochemical and physiological function of
YjhC is particularly useful, given that the 3D structure of this
protein has also recently been solved (20).
The first gene in the yjhBC operon, yjhB, encodes a major
facilitator superfamily (MFS) transporter protein that shows
homology (35% identify, 55% similarity) to NanT, the known
Neu5Ac transporter in E. coli (24, 26, 27). Deletion of nanT
leads to a complete loss of growth on Neu5Ac, suggesting that
YjhB cannot transport this particular sialic acid (28) (Fig. 7A).
Similar to the phenotype observed with the DyjhC strain, the
DyjhBmutant was also unable to grow on 2,7-anhydro-Neu5Ac
but could grow onNeu5Ac (Fig. 7B). The co-expression of these
two genes and the requirement of YjhB for growth on 2,7-anhy-
dro-Neu5Ac suggest that YjhB is a novel MFS transporter for
2,7-anhydro-Neu5Ac and that these two genes together form an
“accessory” operon to allow E. coli to scavenge a wider range of
sialic acids that are available in the human gut. We propose to
rename these genes nanXY, because the function of the final
NanR-regulated operon has been elucidated through this work.
Catabolism of 2,7-anhydro-Neu5Ac is widespread across the
bacterial kingdom
Having demonstrated that NanOx-like genes are functional
in both Gram-positive andGram-negative bacteria, functioning
with different classes of transporters, we extended our analysis
to likely 2,7-anhydro-Neu5Ac catabolic genes across bacterial
species. Genes encoding proteins with high similarity to RgNa-
nOx (percentage identity 49%) were found in diverse
microorganisms across the Firmicutes, Proteobacteria, and
Actinobacterial phyla and were most often co-localized with
other genes for sialic acid catabolism (Fig. 8). Interestingly,
we showed co-occurrence of NanOx genes with known sialic
acid transporters belonging to the MFS transporters, sodium
Figure 4. Analysis of RgNanOx mutants. A, ESI-MS analysis of the enzymatic reaction between RgNanOx mutants and 2,7-anhydro-Neu5Ac (290; left) or
Neu5Ac (308; left). B, DSF analysis of RgNanOx mutants binding to NAD/H cofactor and sialic acid substrates. The DTm is shown compared with the Tm of the
protein alone.
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solute symporter (SSS) transporters, or ABC SAT transporters.
To test the hypothesis that other bacteria can act as “scavengers”
of 2,7-anhydro-Neu5Ac, we heterologously expressed and puri-
fied the NanOx protein from Hemophilus hemoglobinophilus
and showed that the recombinant protein was active against
2,7-anhydro-Neu5Ac (Fig. 6). The analysis also revealed two
additional couplings of NanOx-like genes to likely 2,7-anhydro-
Neu5Ac transporters, namely to transporters of the SSS family,
for example in Streptococcus pneumoniae TIGR4 and a trans-
porter of the GPH family in Lactobacillus salivarius (Fig. 8),
which, together with the phylogenetically broad occurrence of
the NanOx-like genes, suggests that 2,7-anhydro-Neu5Ac use is
not a new trait in bacteria but the result of a symbiotic evolution
of bacteria in themammalian gastrointestinal tract.
Discussion
Given the accessibility of sialic acids in mucus-rich environ-
ments, their utilization offers pathogenic and commensal bac-
teria a competitive advantage to colonize and persist within the
gut (2, 19). The ability of R. gnavus strains to produce and
metabolize 2,7-anhydro-Neu5Ac provides them with a nutri-
tional advantage by scavenging sialic acid from host mucus in a
form that they have preferential access to (4, 17–19). We previ-
ously showed that the oxidoreductase RgNanOx plays a key
role in the catabolism of 2,7-anhydro-Neu5Ac inside the cells
by converting it into Neu5Ac, before being catabolized into
GlcNAc-6-P following the canonical pathway by the successive
action of NanA (Neu5Ac aldolase), NanK (ManNAc kinase),
and NanE (ManNAc-6-P epimerase). However, the molecular
mechanism of RgNanOx enzymatic reaction remained unknown
(19). Here, we showed that RgNanOx acts through a multistep
mechanism involving a keto intermediate and cycling of NADH/
NAD1. The creation of a keto intermediate in sugars is wide-
spread in biology; perhaps it is best-known for the SDR enzyme
UDP-glucose/galactose epimerase (29, 30). In this enzyme, the
oxidation and reduction of the sugar occur so as to invert the
chirality at C4. In other enzymes, including RmlB of the dTDP-L-
rhamnose biosynthetic pathway (31) and the multistep enzyme
Figure 6. Characterization of EcNanOx and HhNanOx. A, ESI-MS analysis of the enzymatic reaction of RgNanOx, EcNanOx, and HhNanOx with 2,7-anhydro-
Neu5Ac (left) or Neu5Ac (right). B, DSF analysis of RgNanOx and EcNanOx, theDTm is shown comparedwith the Tm of the protein alone.
Figure 5. Structure of the sialometabolic nan regulon of E. coli K12 strains and the role of YjhC in sialometabolism by E. coli BW25113. A, structure of
the complete sialometabolic regulon of E. coli K12 strains. The repressor NanR controls expression of only these three loci in E. coli (25), with nanOp indicating
the position of NanR-regulated promoters. The first locus is the core nanATEKyhcH operon for Neu5Ac uptake and dissimilation into the cytoplasm (62). The
two “accessory” loci contain the nanCMS operon, for Neu5Ac uptake through the outer membrane, sialic acid mutarotation, and processing ofO-acetylated si-
alic acids in periplasm (63–65), and the nanXY (yjhBC) operon here characterized as being required for 2,7-anhydro-Neu5Ac uptake and utilization. B–D, growth
of E. coli on different carbon sources. All strains were grown on 2,7-anhydro-Neu5Ac (orange), Neu5Ac (blue), glucose (red), or M9medium alone (black) in 200-
ml microtiter plates.DOD595 for triplicate experiments is shown: BW25113 (B),DyjhC (C), and complemented yjhC (D). Error bars, S.E. of three biological repeats.
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GDP-mannose 3,5-epimerase (32), the creation of a keto group
and the consequent acidification of the a proton(s) allow a range
of chemical reactions. In RgNanOx, by creating a keto group, the
enzyme has acidified the C3 proton; this facilitates an elimination
reaction and formation of a conjugated intermediate 4-keto-
DANA, which we detected by NMR. The NAD1 co-factor is
Figure 8. Diversity of 2,7-anhydro-Neu5Ac catabolic clusters among sialic acid–utilizing bacteria. Gene functions were inferred from BLAST searches
followed by gene linkage and cluster analysis. Orthologous genes are identified with individual patterns. The genes encoding 2,7-anhydro-Neu5Ac transport-
ers, 2,7-anhydro-Neu5Ac oxidoreductases, and IT-sialidases are distinguished by color for emphasis. Nomenclature is as follows. nanA, Neu5Ac lyase; nanK, N-
acetylmannosamine kinase; nanE, N-acetylmannosamine-6-phosphate epimerase; nanC, Neu5Ac outer membrane channel; nanM, Neu5Ac mutarotase; nanS,
N-acetyl-9-O-acetylneuraminate esterase; nagB, glucosamine-6-phosphate deaminase; GNAT, GCN5-related N-acetyltransferase; Reg, regulator (please note
that GNAT family proteins and regulator proteins, while recurrent within clusters, may belong to different clades and thus function differently in each orga-
nism); SAT2, 2,7-anhydro-Neu5Ac transporter of the ABC superfamily; siaPQM, Neu5Ac transporter of the TRAP family; satABCD, Neu5Ac transporter of the ABC
superfamily (SAT); nanUVW (SAT3), Neu5Ac transporter of the ABC superfamily (also named satABC); nanT, Neu5Ac transporter of the MFS superfamily; siaT,
Neu5Ac transporter of the SSS family; nanX (yjhB), 2,7-anhydro-Neu5Ac transporter (nanT-like) of the MFS superfamily ABC;MFS, major facilitator superfamily;
SSS, sodium solute symporter family; GPH, glycoside-pentoside-hexuronide:cation symporter family; SBP, solute-binding protein; TMD, transmembrane do-
main; NBD, nucleotide-binding domain. Note that the classification of ABC sialic acid transporters follows Almagro–Moreno and Boyd (34). *, TIGR4 possesses
both the conserved sialic acid “supercluster,” as in strain D39, and an additional, candidate 2,7-anhydro-Neu5Ac cluster bearing the siaT-like transporter gene.
In TIGR4, the conserved supercluster bears a minor difference in the form of pseudogenes and insertions (66).
Figure 7. Growth of sialometabolism E. coli BW25113 transporter mutants. Both mutants were grown on 2,7-anhydro-Neu5Ac (orange), Neu5Ac (blue),
glucose (red), or M9 medium alone (black) in 200-ml microtiter plates. DOD595 for triplicate experiments is shown: DnanT (A) and DyjhB (B). Error bars, S.E. of
three biological repeats.
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tightly bound, and because in the overall reaction it is unchanged
(acting as co-catalyst), there is no need to recycle it with an addi-
tional enzyme. Instead, the NAD1 is reduced to NADH when it
creates a keto group at C4 of the substrate in the first step, and in
the last stepNAD1 is regenerated by reduction of the keto group.
Previous work using spectrophotometric assays reported
that E. coli YjhC showed a weak interaction with Neu5Ac, with
an apparent Km of 68.8 mM (20). Here, we used ESI-MS to
assess the activity of YjhC against 2,7-anhydro-Neu5Ac or
Neu5Ac. This analysis supported the earlier findings that YjhC
could act on Neu5Ac (20) but also revealed that the enzyme
was able to utilize 2,7-anhydro-Neu5Ac as a substrate in the
samemanner as RgNanOx. Given the structural resemblance of
RgNanOx to YjhC, it is likely that the E. coli oxidoreductase
also uses the same mechanism of action for the reversible con-
version of 2,7-anhydro-Neu5Ac to Neu5Ac.
Further findings from our work support that the catabolism
of 2,7-anhydro-Neu5Ac is not restricted to R. gnavus strains.
E. coli can transport and catabolize the common sialic acid,
Neu5Ac, as a sole source of carbon and nitrogen but also
related sialic acids,N-glycolylneuraminic acid (Neu5Gc) and 3-
keto-3-deoxy-D-glycero-D-galactonononic acid (KDN), which
are transported via the sialic acid transporter NanT and cata-
bolized using the sialic acid aldolase NanA (33). Here, we
showed that E. coli BW25113 strain was able to grow on 2,7-
anhydro-Neu5Ac as a sole carbon source and that the two-gene
NanR-regulated operon nanXY (yjhBC) encodes both the
transporter and oxidoreductase enzyme required for E. coli to
uptake and catabolize 2,7-anhydro-Neu5Ac. This also now
completes the functional characterization of all NanR-regu-
lated genes in E. coli (25), giving us a broader picture of the si-
alic acid molecules it likely encounters in its natural environ-
ment. This ability to utilise multiple sialic acid derivatives
contrasts with R. gnavus strains, which can only grow on 2,7-
anhydro-Neu5Ac but not on Neu5Ac (19) and is consistent
with E. coli being able to integrate diverse sialic acids into its
core catabolic pathway (33). Beyond E. coli, our bioinfor-
matics analyses revealed RgNanOx homologues across many
bacterial species that also co-occurred with predicted sialic
acid transporters.
Bacteria have evolved multiple mechanisms to capture sialic
acid from their environment (34, 35). To date, six different
classes of sialic acid transporters have been described (35).
These include the NanT MFS transporters from E. coli and
Bacteroides fragilis, which in E. coli has been demonstrated bio-
chemically to be a H1-coupled symporter (36). Secondary
transporters implicated in sialic acid transport are from the SSS
family present in pathogens such as Clostridium difficile, Sal-
monella typhimurium, or Proteus mirabilis (28, 37, 38). High-
affinity transport of sialic acid is mediated by substrate-binding
protein-dependent systems, including a tripartite ATP-inde-
pendent periplasmic (TRAP) transporter, SiaPQM, and a num-
ber of different ABC transporters (39–44). The sialic acid ABC
transporters have been further classified into three types: SAT,
SAT2, and SAT3 (34, 35). To date, all of these transporters have
been shown to transport Neu5Ac, with some being able to also
transport the related sialic acids Neu5Gc and KDN (33, 37).
The exception is R. gnavus ABC SAT2 transporter, which we
demonstrated was specific for 2,7-anhydro-Neu5Ac (19). Here,
we showed that in E. coli YjhC (NanY) is associated with a pre-
dicted sialic acid transporter, YjhB (NanX). Our genetic data
suggest that YjhB could transport 2,7-anhydro-Neu5Ac but not
Neu5Ac, where the previously characterized Neu5Ac trans-
porter NanT was not able to transport 2,7-anhydro-Neu5Ac.
Based on its sequence, NanX (YjhB) is classified in the MFS
class of sugar transporters and is a close homologue of NanT.
Our bioinformatics provide striking evidence for two additional
families of secondary transporters having evolved to recognize
2,7-anhydro-Neu5Ac, namely those of the SSS and GPH fami-
lies, bringing the total number of transporter families for 2,7-
anhydro-Neu5Ac to four.
It is of note that E. coli does not encode an IT-sialidase releas-
ing 2,7-anhydro-Neu5Ac; therefore, the ability of this strain to
use 2,7-anhydro-Neu5Ac as ametabolic substrate in vivowould
likely rely on cross-feeding in the mucosal environment. To
date, only R. gnavus strains have been reported to produce 2,7-
anhydro-Neu5Ac from Neu5Ac terminally bound glycoconju-
gates in the gut (4, 5, 18). Resource sharing is an important eco-
logical feature of microbial communities living in the gut (45).
Some bacteria present in the mucus might not be primary
degrader but might cross-feed on mucin glycan degradation
products released by other bacteria. This concept involves the
ability of bacteria to benefit from substrate degradation prod-
ucts but also from fermentation products and plays a crucial
role in microbial community shaping in the gut (46). Such
cross-feeding activities have been reported in the gut mucosal
environment for the utilization of Neu5Ac. For example, Bac-
teroides thetaiotaomicronVPI-5482 encodes a sialidase and can
release free Neu5Ac but lacks the nan operon required to
metabolize the liberated monosaccharide (47). On the other
hand, most C. difficile and S. typhimurium subsp. enterica
strains encode the nan operon but lack the sialidase (48) and
benefit from sialidase-producing organisms such as B. thetaio-
taomicron to acquire this nutrient from the mucosal environ-
ment (49). Our bioinformatics analyses suggest a similar di-
versity for 2,7-anhydro-Neu5Ac metabolism across bacterial
species. For example, whereas R. gnavus possesses the full com-
plement of genes to produce and utilize 2,7-anhydro-Neu5Ac,
including the IT-sialidase (RgNanH), the 2,7-anhydro-Neu5Ac
SAT2 transporter, and the oxidoreductase (RgNanOx) within
the otherwise canonical Nan cluster, E. coli harbors a trans-
porter with specificity for 2,7-anhydro-Neu5Ac (NanX) and
the a NanOx homolog (NanY) but does not express an IT-siali-
dase. Streptococcus pneumoniae strains, on the other hand,
may express up to three sialidases (neuraminidases), NanA,
NanB, and NanC, of which the first two are part of a universally
conserved nan gene cluster (42), whereas the third one is part
of an additional locus present in some strains but not others
(50). The conserved nan cluster is well-studied in strain D39
(42, 51) and is divided into three operons that include operon I
(nanAmonocistronic), operon II (the nanB locus), and operon
III (the nanE locus carrying the catabolic genes) (51). The tran-
scriptomic response of S. pneumoniae D39 to Neu5Ac clearly
demonstrated that NanR acts as a transcriptional activator of
the nan operons I and III in the presence of Neu5Ac, but not
of operon II, for which regulation mechanisms remained
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unknown (51). Because NanB has been functionally character-
ized as an IT-sialidase in S. pneumoniae (52) and the nan op-
eron II also contains a gene encoding an oxidoreductase and a
SAT2 ABC transporter (as in the case of R. gnavus), our results
strongly suggest that the nan operon II is dedicated to 2,7-
anhydro-Neu5Ac utilization. This is also in agreement with the
reported growth assays of S. pneumoniae transporter mutants,
showing that SAT3 was required for Neu5Ac transport but that
growth on Neu5Ac was unaffected in the SAT2 mutant (42),
suggesting that SAT2may be involved in 2,7-anhydro-Neu5Ac,
although this remains to be tested experimentally. The exis-
tence of multiple transporters with different specificities for si-
alic acid derivatives within the same species (e.g. E. coli NanT/
YjhB) or restricted to 2,7-anhydro-Neu5Ac (e.g. R. gnavus
SAT2) points toward divergent evolution of a common ances-
tor. Together, these data demonstrate that 2,7-anhydro-
Neu5Ac catabolism is not exclusive to R. gnavus and may help
shape microbial communities in the gut. From an ecological
point of view, because R. gnavus is the only strain reported to
produce 2,7-anhydro-Neu5Ac in the gut, the strict specificity
of its sialic acid transporter may give it a nutritional advantage
while maintaining its keystone status in the mucus niche by
providing an important nutrient to themicrobial community.
Experimental procedures
Materials and strains
All chemicals were obtained from Sigma unless otherwise
stated. The auto-induction medium “Terrific Broth Base with
Trace Elements” was purchased from ForMedium (Dundee,
UK). 2,7-Anhydro-Neu5Ac was produced as reported by Bell
et al. (19). The E. coli DnanT, DyjhB (JW5768), and DyjhC
(JW5769) mutants all come from the KEIO collection (53) and
are derivatives of BW25113, which we used as WT strain. The
DnanT strain, which we have characterized previously (28, 36)
carries an unmarked deletion, whereas the DyjhB and DyjhC
mutants are unmodified and retain the original Kanmarker.
Bacterial growth assays
Growth curves of E. coli BW25113 and sialometabolism
mutants (DnanT, DyjhC, and DyjhB) before or after comple-
mentation were carried out in M9 medium (without glucose)
supplemented with 11.1 mM Neu5Ac, 2,7-anhydro-Neu5Ac,
or glucose using 200-ml cultures in 96-well microtiter plates.
The OD595 nm was measured every 30 or 60 min for 16 h in a
FLUOstar OPTIMA (BMGLABTECH).
Complementation of E. coli DyjhC
Plasmid pES156 is a derivative of the low-copy plasmid
pWKS30 (67) carrying E. coli yjhBC under the control of the lac
promoter. Tomake pES156, a PCR product for the yjhBC genes
was amplified with primers E549 and E550 (Table S2) cut with
Eco31I (the primers carried sites for this type IIS enzyme that
were designed to produce Acc65I- and BamHI-compatible
ends) and ligated into pWKS30. The constructs were verified
by sequencing. The resulting plasmid was transformed into
chemically competent DyjhC cells using heat shock. For bacte-
rial growth curves, 1 mM isopropyl 1-thio-b-D-galactopyrano-
side was added to the growth medium for induction of the
yjhBC proteins.
Cloning, site-directed mutagenesis, heterologous expression,
and protein purification
RgNanOx was heterologously expressed and purified as
described previously (19). Mutants of RgNanOxwere generated
using the NZYMutagenesis kit (NZYTech) using the primers
listed in Table S2 following the manufacturer’s instructions,
expressed, and purified as described previously for the WT
enzyme (19). Fractions collected following gel filtration were
analyzed using NuPAGE Novex 4–12% BisTris gels (Life Tech-
nologies). Fractions were pooled and concentrated using a
10,000 molecular weight cut-off Vivaspin column (Vivaspin,
Germany). Protein concentration was determined by a Nano-
Drop spectrophotometer (Thermo Scientific) using extinction
coefficients calculated by Protparam (ExPASy-Artimo, 2012)
from the peptide sequence.
The oxidoreductase genes encoding YjhC from E. coli
BW25113 and the homologue in H. hemoglobinophilus CCUG
3714 (B0186_5960; strain purchased fromDSMZ, reference no.
DSM21241) were amplified from genomic DNA with Hercula-
seIIFusion (Agilent) using primer pairs E521 plus E522 and
ES525 plus ES526, respectively (Table S2).The PCR products,
each flanked by sites for type IIS enzyme Eco31I (BsaI) designed
to produce NcoI and XhoI compatible ends, were digested with
Eco31I and ligated in pET28a digested with NcoI and XhoI.
The resulting constructs were confirmed by sequencing.
For purification of these recombinant proteins, the corre-
sponding expression plasmids were transformed into BL21
(DE3) pLysS, and single colonies were grown overnight in 10
ml of lysogeny broth with Cm15 Kan25. These starter cultures
were used to inoculate 1 liter of Terrific Broth (Terrific Broth
47.6 g/liter, glycerol 0.5% (v/v)) with antibiotics. Cultures were
grown in baffled flasks at 37 °C and 200 rpm until 0.7 OD650
before being quickly chilled on ice-water for about 20 min and
finally induced overnight with 0.2mM isopropyl 1-thio-b-D-gal-
actopyranoside at 18 °C and 220 rpm. After harvest, pellets
were resuspended in equilibration buffer (50 mM KPi, 200 mM
NaCl, 20% glycerol, 40 mM imidazole, pH 7.8) and disrupted
with sonication. The clarified lysate was run through an immo-
bilized metal affinity chromatography column to elute the C-
terminal His6-tagged proteins, which eluted in sharp peaks
with a single 500 mM imidazole step. These were further puri-
fied by size-exclusion chromatography with elution in 50 mM
KPi, 200 mMNaCl, pH 7.8, dialyzed against assay buffer (20 mM
Tris, 150 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine, pH
7.5), and finally concentrated to 0.5–1 mM for storage at 4 °C.
Purity was assessed on SDS-PAGE as above.
ESI-MS analysis of the oxidoreductase reaction
To assay for oxidoreductase activity, the purified recombi-
nant proteins were incubated in 100-ml reactions at 37 °C over-
night with 1 mg/ml 2,7-anhydro-Neu5Ac or Neu5Ac in 20 mM
sodium phosphate buffer, pH 7.5, in the presence 500 mM
NADH. The conversion of 2,7-anhydro-Neu5Ac to Neu5Ac or
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Neu5Ac to 2,7-anhydro-Neu5Ac was monitored by ESI-MS.
Briefly, 100 ml of acetonitrile was added to each reaction, vor-
texed, and centrifuged to remove particles. The resulting super-
natants were loaded onto an AmaZon Speed ETD (Bruker)
mass spectrometer and analyzed by direct injection in negative
mode.
NMR analyses of the oxidoreductase reaction
All 1D NMR experiments were performed using a Bruker
Advance I 500-MHz spectrometer with a 5-mm PATXI 1H/D-
13C/15N Z-GRD probe at 293 K. To follow the kinetics of the
reaction and assess the position of deuteration, two samples
containing 2 mM 2,7-anhydro-Neu5Ac, 100 mM NADH, and 60
mM RgNanOx were used, one in deuterated PBS buffer (PBS/
D2O) and one in standard PBS buffer (PBS/H2O, containing
10% D2O for locking purposes). The reaction was followed by
acquiring 1D NMR experiments at 15-min intervals over 24 h.
The standard zg pulse sequence was used for the D2O sample,
whereas excitation sculpting was used to remove the strong sol-
vent signals for the H2O sample (pulse sequence: zgesgp). 1 mM
DSS-d6 was added to each sample as an internal reference, and
the signal was calibrated to 0 ppm. All 2D NMR experiments
were performed using an Avance NEO 600-MHz NMR spec-
trometer equipped with He-cooled TCI cryoprobe. Typically, a
spectral width of 12 ppm was used for 1H and 165 ppm for 13C,
acquiring 8 scans/experiment with a time domain of 2048 data
points in the direct dimension and 128 experiments in the indi-
rect dimension. To characterize the reaction intermediate, a
sample containing 3 mM 2,7-anhydro-Neu5Ac, 100 mMNADH,
15 mM RgNanOx, and 1 mM DSS-d6 in PBS/D2O was prepared
and analyzed at 293 K. A full set of 2D NMR experiments, in-
cluding HSQC (hsqcetgpsi), COSY (cosygpqf), TOCSY (mlevph)
and TOCSY-HSQC (hsqcdietgpsi), was acquired to fully assign
1Hand 13C signals of the intermediate.
DSF
The Applied Biosystems StepOnePlus Real-Time PCR sys-
tem (Life Technologies) was used to record the thermal stabil-
ity of the purified proteins with and without substrates or
cofactors. Reactions were performed in 20 mM sodium phos-
phate, pH 7.5, and consisted of 5 mM protein, 53 SYPRO
Orange (prepared as a 403 stock), 10 mM substrate (2,7-anhy-
dro-Neu5Ac or Neu5Ac), 1 mM cofactor (NAD or NADH) in a
20-ml final reaction volume. Samples were heated from 10 to
99 °C in 0.5 °C increments, taking fluorescent readings at each
time point. Triplicate measurements were performed for each
sample. Negative controls were included for each component
of the experiment individually as well as a dye-only control
well. The melting point (Tm) of each sample in °C was obtained
from the lowest point of the first derivative plot.
Crystallization, data collection, and structure determination
of RgNanOX
Sitting-drop vapor diffusion crystallization experiments of
RgNanOx were set up at a concentration of 20 mg/ml. The
structure was acquired from a crystal grown in the JCSG Plus
screen (100 mM sodium citrate, pH 5.5, 20% PEG 3000). The
diffraction experiment was performed on the I04 beamline at
Diamond Light Source Ltd. at 100 K using a wavelength of
0.9795 Å. The data were processed with Xia2 pipeline. The
structure was phased using online MrBUMP Sculptor pipeline
(54) with PDB entry 5UI9. Refinement was carried out using
Phenix AutoBuild (55), Refmac (56), and PDB REDO (57). Coot
(58) was used for manual model building and Molprobity (59)
for structure validation. It has not yet been possible to obtain
well-diffracting crystals of any substrate analog complex of the
protein. For modeling, after manual positioning in COOT, the
structure was idealized using REFMAC5 (56).
Bioinformatics
To search and compare protein sequences for RgNanOx, the
BLAST program and BLASTp (60) were used. The DALI server
(61) was used for protein structure comparison. Amino acid
sequences and atomic structures of homologues were sourced
from the NCBI/UniProt and PDB databases, respectively.
BLAST searches were initiated with RgNanOx/YjhC as queries
followed by manual annotation of the ORFs going outward. To
map complete sialometabolic pathways within individual
microorganisms, BLAST searches were performed against all
known Neu5Ac transporters (35) as well as for the Neu5Ac al-
dolase NanA and N-acetylmannosamine-6-phosphate epimer-
ase NanE (using queries of different organismal origin). This
was carried out to include annotation of genes for RgNanOx
homologues residing outside the cluster or wheremultiple sialo-
metabolic clusters were present.
Data availability
The atomic coordinates have been deposited in the Protein
Data Bank under accession codes 6Z3B (2.58 Å resolution
structure of RgNanOx), and 6Z3C (1.74 Å resolution structure
of RgNanOx). All other data supporting the findings of this
study are available within the article and the supplemental
information.
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